The National Development and Reform Commission is considering an end to price caps on most drugs sold in China, Bloomberg reported, citing a proposal sent to drug industry groups. Under the proposed plan, which would take effect on January 1, the government would let prices be set by the market and impose measures to keep drug costs from spiking. Price controls for certain products such as anesthesia drugs would remain. China currently imposes price controls on most medicines on the mainland through caps and other methods such as state-run tenders in order to contain health-care costs.
Categories